COVID-19 vaccine hesitancy among pregnant women attending tertiary care centre: A cross-sectional study. 2023

Nidhi Gupta, and Sumedha Sharma, and Aruna Nigam, and Sanjeet Panasar, and Siddharth Kumar
Department of Obstetrics & Gynaecology, Hamdard Institute of Medical Science & Research and Hakeem Abdul Hameed Centenary Hospital, New Delhi, India.

OBJECTIVE To evaluate the knowledge and attitude towards coronavirus disease 2019 (COVID-19) vaccination during pregnancy and to discover factors that lead to non-acceptance of vaccine. METHODS A cross-sectional study was performed in the Department of Obstetrics and Gynecology, Hamdard Institute of Medical Science & Research, New Delhi over a period of 3 months through a web-based questionnaire via Google form. The questionnaire was assessed using Cronbach α for internal consistency, which was 0.795. RESULTS News (74%) was the major source of knowledge among pregnant women. Around 60% women were not willing to receive the vaccine, mainly because of their fear of a harmful effect on pregnancy. The anticipated vaccine acceptance rate was 41% but actual vaccine acceptance rate in pregnancy was 7.3%. CONCLUSIONS Efforts should be made to reduce the gap of knowledge regarding vaccine among pregnant women.

UI MeSH Term Description Entries
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086663 COVID-19 Vaccines Vaccines or candidate vaccines containing SARS-CoV-2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent COVID-19. 2019 Novel Coronavirus Vaccine,2019 Novel Coronavirus Vaccines,2019-nCoV Vaccine,2019-nCoV Vaccines,COVID 19 Vaccine,COVID-19 Vaccine,COVID-19 Virus Vaccine,COVID-19 Virus Vaccines,COVID19 Vaccine,COVID19 Vaccines,COVID19 Virus Vaccine,COVID19 Virus Vaccines,Coronavirus Disease 2019 Vaccine,Coronavirus Disease 2019 Vaccines,Coronavirus Disease 2019 Virus Vaccine,Coronavirus Disease 2019 Virus Vaccines,Coronavirus Disease-19 Vaccine,Coronavirus Disease-19 Vaccines,SARS Coronavirus 2 Vaccines,SARS-CoV-2 Vaccine,SARS-CoV-2 Vaccines,SARS2 Vaccine,SARS2 Vaccines,2019 nCoV Vaccine,2019 nCoV Vaccines,COVID 19 Vaccines,COVID 19 Virus Vaccine,COVID 19 Virus Vaccines,Coronavirus Disease 19 Vaccine,Coronavirus Disease 19 Vaccines,SARS CoV 2 Vaccine,SARS CoV 2 Vaccines,Vaccine, 2019-nCoV,Vaccine, COVID 19,Vaccine, COVID-19,Vaccine, COVID-19 Virus,Vaccine, COVID19,Vaccine, COVID19 Virus,Vaccine, Coronavirus Disease-19,Vaccine, SARS-CoV-2,Vaccine, SARS2,Vaccines, 2019-nCoV,Vaccines, COVID-19,Vaccines, COVID-19 Virus,Vaccines, COVID19,Vaccines, COVID19 Virus,Vaccines, Coronavirus Disease-19,Vaccines, SARS-CoV-2,Vaccines, SARS2,Virus Vaccine, COVID-19,Virus Vaccine, COVID19,Virus Vaccines, COVID-19,Virus Vaccines, COVID19
D062606 Tertiary Care Centers A medical facility which provides a high degree of subspecialty expertise for patients from centers where they received SECONDARY CARE. Tertiary Hospital,Tertiary Referral Center,Tertiary Referral Hospital,Care Center, Tertiary,Care Centers, Tertiary,Center, Tertiary Care,Center, Tertiary Referral,Centers, Tertiary Care,Centers, Tertiary Referral,Hospital, Tertiary,Hospital, Tertiary Referral,Hospitals, Tertiary,Hospitals, Tertiary Referral,Referral Center, Tertiary,Referral Centers, Tertiary,Referral Hospital, Tertiary,Referral Hospitals, Tertiary,Tertiary Care Center,Tertiary Hospitals,Tertiary Referral Centers,Tertiary Referral Hospitals
D037841 Pregnant Women Human females who are pregnant, as cultural, psychological, or sociological entities. Women, Pregnant,Pregnant Woman,Woman, Pregnant

Related Publications

Nidhi Gupta, and Sumedha Sharma, and Aruna Nigam, and Sanjeet Panasar, and Siddharth Kumar
September 2023, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
Nidhi Gupta, and Sumedha Sharma, and Aruna Nigam, and Sanjeet Panasar, and Siddharth Kumar
July 2022, JNMA; journal of the Nepal Medical Association,
Nidhi Gupta, and Sumedha Sharma, and Aruna Nigam, and Sanjeet Panasar, and Siddharth Kumar
June 2023, The Australian & New Zealand journal of obstetrics & gynaecology,
Nidhi Gupta, and Sumedha Sharma, and Aruna Nigam, and Sanjeet Panasar, and Siddharth Kumar
October 2022, Vaccines,
Nidhi Gupta, and Sumedha Sharma, and Aruna Nigam, and Sanjeet Panasar, and Siddharth Kumar
January 2022, Indian journal of public health,
Nidhi Gupta, and Sumedha Sharma, and Aruna Nigam, and Sanjeet Panasar, and Siddharth Kumar
June 2023, Cureus,
Nidhi Gupta, and Sumedha Sharma, and Aruna Nigam, and Sanjeet Panasar, and Siddharth Kumar
September 2022, JNMA; journal of the Nepal Medical Association,
Nidhi Gupta, and Sumedha Sharma, and Aruna Nigam, and Sanjeet Panasar, and Siddharth Kumar
January 2022, JNMA; journal of the Nepal Medical Association,
Nidhi Gupta, and Sumedha Sharma, and Aruna Nigam, and Sanjeet Panasar, and Siddharth Kumar
January 2023, PloS one,
Nidhi Gupta, and Sumedha Sharma, and Aruna Nigam, and Sanjeet Panasar, and Siddharth Kumar
June 2023, JNMA; journal of the Nepal Medical Association,
Copied contents to your clipboard!